fig.3.b

Peyrot SM et al. (2011)

Xla Wt + Cyclopamine

NF17 (in situ hybridization)

Expression Phenotype
decreased amount ntn1.L expression in floor plate

fig.6.g

Peyrot SM et al. (2011)

Xla Wt + Cyclopamine

NF20-22 (in situ hybridization)

Expression Phenotype
decreased amount ntn1.L expression in floor plate

fig.3.c

Peyrot SM et al. (2011)

Xla Wt + shh

NF17 (in situ hybridization)

Expression Phenotype
increased amount ntn1.L expression in floor plate

fig.6.i

Peyrot SM et al. (2011)

Xla Wt + shh

NF20-22 (in situ hybridization)

Expression Phenotype
increased amount ntn1.L expression in neural tube

fig.3.b

Peyrot SM et al. (2011)

Xla Wt + shh MO

NF17 (in situ hybridization)

Expression Phenotype
decreased amount ntn1.L expression in floor plate

fig.6.c

Peyrot SM et al. (2011)

Xla Wt + shh MO

NF20-22 (in situ hybridization)

Expression Phenotype
decreased amount ntn1.L expression in floor plate

fig.1.c

Peyrot SM et al. (2011)

Xla Wt + canotch1

NF17 (in situ hybridization)

Expression Phenotype
increased amount ntn1.L expression in neural plate mislocalised ntn1.L expression in neural plate

fig.6.b, f

Peyrot SM et al. (2011)

Xla Wt + canotch1

NF20-22 (in situ hybridization)

Expression Phenotype
increased amount ntn1.L expression in neural tube

fig.1.b

Peyrot SM et al. (2011)

Xla Wt + dnrbpj

NF17 (in situ hybridization)

Expression Phenotype
decreased amount ntn1.L expression in floor plate

fig.6.j

Peyrot SM et al. (2011)

Xla Wt + dnrbpj

NF20-22 (in situ hybridization)

Expression Phenotype
decreased amount ntn1.L expression in floor plate